Working group: Digital technologies
Digital technologies are at the heart of tomorrow's diagnostics. The entire value chain of digital diagnostics is therefore mapped in the corresponding working group. From the primary generation of data by service providers to the secondary use of data for the development of new diagnostics - without digital technologies, diagnostics will no longer be conceivable in the future.
The members of the working group, consisting of representatives from the areas of digital transformation/IT, business and market development as well as regulatory affairs and quality management systems, deal with new innovations for diagnostics and their significance for the industry. The topics of the Digital Technologies Working Group range from artificial intelligence, data use and data protection, connection to the telematics infrastructure to interoperability.
The working group also regularly invites external guests to give presentations on these topics. For example, they present innovations in the areas of data usage, artificial intelligence or simple access to diagnostics. In the future, the working group would like to focus even more intensively on the possibilities of data usage in order to provide patients with even better diagnostics with the help of new digital technologies. In addition, the Digital Technologies working group has set itself the goal of conducting and consolidating a professional exchange on diagnostically relevant digital technologies, transferring the expertise from the professional exchange to the Digital Committee and making best practices in the field of digital technologies available to members.
As a working group of the Digital Committee, the Digital Technologies Working Group also deals with numerous practice-relevant topics. One of these is the use of data in accordance with Section 303e SGB V. The initial focus here is on issues relating to data generation in laboratory devices. This data is then transferred interoperably to the electronic patient file by the service providers. After anonymization, the data is then transferred to the Health Research Data Centre or to clinical cancer registries. With the help of an application form and a research question, the data can then be used by companies for the development of new diagnostics in compliance with data protection regulations.
